Thioredoxin Systems AB is a growing organisation, supported by an expert advisory board, dedicated to the development of EbsArgentTM as a new solution to antimicrobial resistance.


Patrik Gille-Johnson, MD

Patrik has been working as an MD Infectious Diseases Consultant at Danderyds Sjukhus AB and Karolinska Universitetssjukhuset for many years and has from this position gained a deep understanding of the challenges of antimicrobial resistance and the need for novel therapeutic options.

Annette Alaeus, MD-PhD

Annette is a highly experienced infection specialist and has worked as Medical Director at Bristol Myers Squibb. She is currently a Senior Consultant and a member of the Medical Quality Team at Kry, with particular involvement in their “Global Team Covid-19”.

Tomas N Gustafsson, MD-PhD

Tomas is a Physician at the Infectious Disease Clinic at Sunderby Hospital, Luleå, and a researcher at the Department of Clinical Microbiology, Umeå University. His primary research interest includes early antibiotic development as well as development of methods to help bridge gaps in the antibiotic development pipeline.